Development
Traws Pharma, Inc.
TRAW
$1.50
-$0.025-1.65%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -4.74M | -4.25M | -5.78M | -5.42M | -5.40M |
| Total Depreciation and Amortization | 5.00K | 4.00K | 3.00K | 4.00K | 3.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 360.00K | 273.00K | 336.00K | 330.00K | 305.00K |
| Change in Net Operating Assets | -95.00K | -517.00K | 893.00K | 1.20M | 1.19M |
| Cash from Operations | -4.47M | -4.49M | -4.54M | -3.88M | -3.90M |
| Capital Expenditure | -14.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -2.00K | -1.00K | 6.00K | 28.00K | -20.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.49M | -4.49M | -4.54M | -3.86M | -3.92M |